Literature DB >> 18363640

Childhood spinal muscular atrophy induces alterations in contractile and regulatory protein isoform expressions.

L Stevens1, B Bastide, C A Maurage, E Dupont, V Montel, C Cieniewski-Bernard, J M Cuisset, L Vallée, Y Mounier.   

Abstract

AIMS: Although modifications of the survival motor neurone gene are responsible for most spinal muscular atrophy (SMA) cases, the molecular pathophysiology and the muscular target proteins involved are still unknown. The aim of this study was to compare the expression of contractile and regulatory protein isoforms in quadriceps muscles from SMA children with age-matched control quadriceps.
METHODS: The isoform patterns of myosin heavy chains (MHC), troponin subunits (T, C and I) and tropomyosin were determined by immunoblotting, reverse transcription-polymerase chain reaction and mass spectrometry analyses. Depending on the disease severity, their expression levels were followed in specific variants of SMA populations (types I, II and III), with comparison with age-matched control muscles.
RESULTS: The isoform transitions in SMA muscles were different from the fast-to-faster transitions occurring in normal muscles from children aged 1 month to 5 years old. Moreover, the expression of the neonatal MHC isoform was not repressed in SMA muscles.
CONCLUSIONS: The presence of the neonatal MHC isoform in SMA muscles indicates an alteration of the phenotype in these diseased muscles. It is strongly suggested that MHC and troponin T proteins may be good markers for the SMA pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363640     DOI: 10.1111/j.1365-2990.2008.00950.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  10 in total

1.  Higher expression of myosin heavy chain IIx in wrist flexors in cerebral palsy.

Authors:  Stefan Gantelius; Yvette Hedström; Eva Pontén
Journal:  Clin Orthop Relat Res       Date:  2012-05       Impact factor: 4.176

2.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

3.  Increased IGF-1 in muscle modulates the phenotype of severe SMA mice.

Authors:  Marta Bosch-Marcé; Claribel D Wee; Tara L Martinez; Celeste E Lipkes; Dong W Choe; Lingling Kong; James P Van Meerbeke; Antonio Musarò; Charlotte J Sumner
Journal:  Hum Mol Genet       Date:  2011-02-16       Impact factor: 6.150

4.  New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1.

Authors:  Heike Kölbel; Florian Kraft; Andreas Hentschel; Artur Czech; Andrea Gangfuss; Payam Mohassel; Chi Nguyen; Werner Stenzel; Ulrike Schara-Schmidt; Corinna Preuße; Andreas Roos
Journal:  Genes (Basel)       Date:  2022-05-17       Impact factor: 4.141

5.  Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.

Authors:  Charlotte J Sumner; Claribel D Wee; Leigh C Warsing; Dong W Choe; Andrew S Ng; Cathleen Lutz; Kathryn R Wagner
Journal:  Hum Mol Genet       Date:  2009-05-28       Impact factor: 6.150

6.  Inducible depletion of adult skeletal muscle stem cells impairs the regeneration of neuromuscular junctions.

Authors:  Wenxuan Liu; Lan Wei-LaPierre; Alanna Klose; Robert T Dirksen; Joe V Chakkalakal
Journal:  Elife       Date:  2015-08-27       Impact factor: 8.140

7.  Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy.

Authors:  Shinichiro Yamada; Atsushi Hashizume; Yasuhiro Hijikata; Tomonori Inagaki; Keisuke Suzuki; Naohide Kondo; Kaori Kawai; Seiya Noda; Hirotaka Nakanishi; Haruhiko Banno; Akihiro Hirakawa; Haruki Koike; Katherine Halievski; Cynthia L Jordan; Masahisa Katsuno; Gen Sobue
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

8.  The Ca2+ sensitizer CK-2066260 increases myofibrillar Ca2+ sensitivity and submaximal force selectively in fast skeletal muscle.

Authors:  Darren T Hwee; Arthur J Cheng; James J Hartman; Aaron C Hinken; Ken Lee; Nickie Durham; Alan J Russell; Fady I Malik; Håkan Westerblad; Jeffrey R Jasper
Journal:  J Physiol       Date:  2017-01-24       Impact factor: 5.182

9.  Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.

Authors:  Claudia Malacarne; Mariarita Galbiati; Eleonora Giagnorio; Paola Cavalcante; Franco Salerno; Francesca Andreetta; Cinza Cagnoli; Michela Taiana; Monica Nizzardo; Stefania Corti; Viviana Pensato; Anna Venerando; Cinzia Gellera; Silvia Fenu; Davide Pareyson; Riccardo Masson; Lorenzo Maggi; Eleonora Dalla Bella; Giuseppe Lauria; Renato Mantegazza; Pia Bernasconi; Angelo Poletti; Silvia Bonanno; Stefania Marcuzzo
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 10.  Therapeutic strategies for spinal muscular atrophy: SMN and beyond.

Authors:  Melissa Bowerman; Catherina G Becker; Rafael J Yáñez-Muñoz; Ke Ning; Matthew J A Wood; Thomas H Gillingwater; Kevin Talbot
Journal:  Dis Model Mech       Date:  2017-08-01       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.